(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -21.57%42.09M | 195.85%164.79M | 1,377.74%53.67M | -61.49%55.7M | -107.40%-4.2M | 275.16%144.63M | 403.78%56.73M | -42.35%38.55M | -154.87%-18.68M | 2.46%66.87M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -179.01%-1.01M | 21.64%-1.33M | 59.96%-362K | -1.25%-1.7M | -159.03%-904K | 24.07%-1.68M | 76.05%-349K | -264.03%-2.21M | -198.57%-1.46M | -225.81%-606K |
Attributable subsidiary (profit) loss | -420.11%-1.18M | -1,208.10%-4.2M | --368K | -108.41%-321K | ---- | 624.48%3.82M | 123.23%567K | 32.41%527K | 786.49%254K | -71.12%398K |
Impairment and provisions: | 775.45%1.13M | -88.91%1.03M | -120.69%-167K | 552.88%9.3M | -61.70%807K | 188.26%1.42M | 147.88%2.11M | 196.11%494K | 10.82%850K | -143.56%-514K |
-Impairment of trade receivables (reversal) | 775.45%1.13M | -88.50%1.03M | -120.69%-167K | 529.42%8.96M | -61.70%807K | 188.26%1.42M | 147.88%2.11M | -37.15%494K | 10.82%850K | -33.39%786K |
-Other impairments and provisions | ---- | ---- | ---- | --334K | ---- | ---- | ---- | ---- | ---- | ---1.3M |
Revaluation surplus: | ---- | 1,057.14%3.81M | ---- | --329K | ---- | ---- | ---- | 168.18%480K | 830.00%511K | -144.44%-704K |
-Other fair value changes | ---- | 1,057.14%3.81M | ---- | --329K | ---- | ---- | ---- | 168.18%480K | --511K | -144.44%-704K |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -235.33%-586K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -235.33%-586K |
Depreciation and amortization: | 0.80%2.65M | 1.37%5.19M | 10.62%2.63M | -17.33%5.12M | -19.07%2.37M | -11.76%6.2M | 13.86%2.93M | 61.75%7.02M | 63.70%2.58M | 11.59%4.34M |
-Amortization of intangible assets | 68.75%135K | 63.41%201K | -48.05%80K | -5.38%123K | 156.67%154K | 18.18%130K | 7.14%60K | -13.39%110K | -5.08%56K | 8.55%127K |
Financial expense | -24.12%151K | -22.05%410K | -16.39%199K | -14.19%526K | -21.19%238K | -75.63%613K | -84.24%302K | -44.30%2.52M | 231.49%1.92M | 366.43%4.52M |
Special items | 154.74%9.59M | -47.90%9.75M | -46.21%3.76M | 1,633.36%18.71M | --7M | -713.33%-1.22M | ---- | 86.89%-150K | ---- | -525.28%-1.14M |
Operating profit before the change of operating capital | -11.12%53.41M | 104.70%179.44M | 1,031.66%60.09M | -43.00%87.66M | -91.48%5.31M | 225.58%153.79M | 544.10%62.29M | -34.91%47.23M | -138.58%-14.03M | -0.46%72.57M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | 130.00%191.79M | -4.27%-89.81M | 89.66%83.39M | -727.06%-86.13M | 209.16%43.97M | 80.30%-10.41M | -144.09%-40.28M | -160.40%-52.87M | 83.58%91.36M | 261.12%87.54M |
Accounts payable increase (decrease) | -185.42%-146.42M | -16.50%62.7M | 53.83%-51.3M | 11.48%75.09M | -471.83%-111.11M | 1,113.26%67.36M | 136.36%29.88M | 115.52%5.55M | -190.92%-82.18M | -163.61%-35.76M |
prepayments (increase)decrease | 52.43%-8.93M | -106.41%-1.04M | 12.65%-18.78M | 1,225.59%16.23M | -134.71%-21.5M | 91.39%-1.44M | 41.81%-9.16M | -357.58%-16.75M | 3.30%-15.74M | 6.73%6.5M |
Cash from business operations | 22.41%89.85M | 62.93%151.29M | 188.08%73.4M | -55.63%92.86M | -295.01%-83.33M | 1,343.33%209.29M | 307.56%42.73M | -112.86%-16.83M | -149.50%-20.59M | 61.75%130.84M |
Other taxs | -82.25%-29.43M | -13.56%-36.17M | 26.30%-16.15M | 6.10%-31.86M | -20.67%-21.91M | -177.45%-33.93M | -68.92%-18.16M | 51.88%-12.23M | 35.34%-10.75M | -12.97%-25.41M |
Net cash from operations | 5.53%60.42M | 88.72%115.12M | 154.40%57.26M | -65.21%61M | -528.19%-105.24M | 703.43%175.36M | 178.43%24.58M | -127.56%-29.06M | -225.49%-31.34M | 80.55%105.43M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 179.01%1.01M | -21.64%1.33M | -59.96%362K | 1.25%1.7M | 159.03%904K | -24.07%1.68M | -76.05%349K | 264.03%2.21M | 198.57%1.46M | 225.81%606K |
Loan receivable (increase) decrease | ---- | -94.91%-651K | ---- | ---334K | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 192.46%8.27M | --8.94M | ---8.94M |
Sale of fixed assets | ---- | 2,800.00%29K | ---- | -95.45%1K | -92.31%1K | -63.33%22K | 116.67%13K | --60K | --6K | ---- |
Purchase of fixed assets | -86.89%-998K | 79.40%-656K | 76.06%-534K | 25.12%-3.18M | -552.34%-2.23M | -372.97%-4.25M | 33.72%-342K | -2.86%-899K | -12.17%-516K | 18.39%-874K |
Purchase of intangible assets | 83.94%-101K | -684.38%-753K | -2,319.23%-629K | 53.17%-96K | 75.70%-26K | -6.22%-205K | ---107K | -18.40%-193K | ---- | -213.46%-163K |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.2M |
Cash on investment | ---- | ---- | ---- | ---36.79M | -20.56%-19.91M | ---- | ---16.51M | ---- | ---- | ---- |
Other items in the investment business | ---- | --198K | ---- | ---- | ---- | 178.90%3.11M | ---- | -82.35%1.11M | -76.83%613K | --6.31M |
Net cash from investment operations | 88.89%-89K | 98.70%-504K | 96.23%-801K | -11,254.76%-38.71M | -28.07%-21.26M | -96.71%347K | -258.10%-16.6M | 667.11%10.55M | 301.22%10.5M | 61.95%-1.86M |
Net cash before financing | 6.87%60.33M | 414.11%114.62M | 144.63%56.45M | -87.31%22.29M | -1,685.62%-126.5M | 1,049.42%175.71M | 138.29%7.98M | -117.87%-18.51M | -175.53%-20.84M | 93.57%103.57M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 91.83%74.81M |
Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -293.75%-74.81M | -293.75%-74.81M | 5.00%-19M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 406,461.36%357.77M | --357.78M | --88K |
Interest paid - financing | 24.12%-151K | 22.05%-410K | 16.39%-199K | 14.19%-526K | 21.19%-238K | 75.63%-613K | 84.24%-302K | 44.30%-2.52M | -231.49%-1.92M | -366.43%-4.52M |
Dividends paid - financing | -81.89%-69.57M | 19.26%-81.74M | -502.01%-38.25M | -102.91%-101.23M | ---6.35M | ---49.89M | ---- | ---- | ---- | 24.94%-40.6M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | -74.59%-10.19M | -60.66%-9.21M | 88.72%-5.84M | 88.33%-5.73M | ---51.74M | ---49.09M | ---- |
Other items of the financing business | ---- | -36.60%-18.69M | ---1.01M | -94.37%-13.68M | ---- | 69.36%-7.04M | 100.60%80K | 68.29%-22.97M | ---13.28M | ---72.45M |
Net cash from financing operations | -73.82%-71.3M | 18.42%-103.97M | -148.43%-41.02M | -84.93%-127.44M | -96.05%-16.51M | -134.50%-68.91M | -103.89%-8.42M | 411.88%199.73M | 1,909.13%216.59M | -65.32%-64.04M |
Effect of rate | -195.70%-7.49M | -843.24%-3.84M | -172.01%-2.53M | 89.62%-407K | 264.38%3.52M | 49.63%-3.92M | -130.05%-2.14M | -597.00%-7.78M | 4,520.50%7.12M | -44.43%1.57M |
Net Cash | -171.05%-10.97M | 110.13%10.65M | 110.79%15.44M | -198.44%-105.14M | -32,109.91%-143.01M | -41.07%106.8M | -100.23%-444K | 358.45%181.23M | 1,153.54%195.75M | 167.67%39.53M |
Begining period cash | 2.27%307.08M | -26.01%300.27M | -26.01%300.27M | 33.96%405.82M | 33.96%405.82M | 133.94%302.94M | 133.94%302.94M | 46.49%129.49M | 46.49%129.49M | 24.84%88.4M |
Cash at the end | -7.84%288.63M | 2.27%307.08M | 17.59%313.17M | -26.01%300.27M | -11.33%266.32M | 33.96%405.82M | -9.63%300.35M | 133.94%302.94M | 220.04%332.36M | 46.49%129.49M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data